Biotech Representative Asks Legislature to Prepare for Possible FDA Approval of Synthetic Psilocybin Tess Butler of Compass Pathways requested that the committee adopt language to allow timely state rescheduling and patient access to COM‑360 (synthetic psilocybin) if the FDA approves and the DEA reschedules the product.

Vermont may soon pave the way for a groundbreaking treatment for depression and PTSD with synthetic psilocybin, but it needs your voice to ensure timely access!

Learn more here

#VT #RegulatoryChange #CitizenPortal #InnovativeTreatment #VermontPatients #MentalHealth